Jose Serna
Spain

Current Job

• Director IVI Zaragoza

Education & Training

• Master Assisted Reproduction UNED 2003
• Ph.D. in Biochemistry and Molecular Biology. Universidad Complutense de Madrid 1998
• Degree in Medicine and Surgery. Universidad Complutense de Madrid 1993  

Research Activity

• ENSAYO CLÍNICO, UNICÉNTRICO, PAREADO NO ALEATORIZADO PARA LA EVALUACIÓN DE LA PERFUSIÓN Y ESTRUCTURA UTERINAS MEDIANTE FRACCIÓN SANGUÍNEA EN MOVIMIENTO, ECOGRAFÍA CON CONTRASTE Y TEXTURIZACIÓN, EN MODO ECOGRÁFICO 2D, 3D Y 4D José Serna López. (IVI Zaragoza, S.L.). 30/11/2015-30/11/2017. 232.765 €.
• Plataforma Observacional de Test de Reserva Ovárica en Mujeres Pobre Respondedoras. MERCK SL. Guillermo Antiñolo. 01/10/2014-01/10/2015.
• ESPART Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology. ClinicalTrials.gov Identifier: NCT02047227 Merck KGaA. Desde 01/01/2014.
• ESTHER I A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre, Multinational Trial Comparing the Efficacy and Safety of FE 999049 With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology Programme Ferring Pharmaceuticals. 01/10/2013.
• BASIC Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions Ferring Pharmaceuticals. Ferring Pharmaceuticals. Desde 01/11/2012.
• ESTHER-2 Evidence-based Stimulation Trial with Human rFSH in Europe and Rest of World Ferring Pharmaceuticals. Ferring Pharmaceuticals.